Methods for the treatment of a normal pressure hydrocephalus

Details Methods for the treatment of a normal pressure hydrocephalus Methods for the treatment of a normal pressure hydrocephalus

2007-03-13

2007-03-13

Sirmons, Kevin C. (Department: 3767)

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

C604S009000

Reexamination Certificate

active

10382086

ABSTRACT:
Normal pressure hydrocephalus is treated by removing cerebralspinal fluid (CSF) from a CSF space of a patient. In particular, CSF is drained while pressure within the CSF space remains within an expected normal range for the patient.

REFERENCES:
patent: 3111125 (1963-11-01), Schulte
patent: 3886948 (1975-06-01), Hakim
patent: 3889687 (1975-06-01), Harris et al.
patent: 3913587 (1975-10-01), Newash
patent: 3985140 (1976-10-01), Harris
patent: 4156422 (1979-05-01), Hildebrandt et al.
patent: 4261341 (1981-04-01), Hakim et al.
patent: 4375816 (1983-03-01), Labianca
patent: 4377169 (1983-03-01), Banks
patent: 4385636 (1983-05-01), Cosman
patent: 4432853 (1984-02-01), Banks
patent: 4532932 (1985-08-01), Batty, Jr.
patent: 4540400 (1985-09-01), Hooven
patent: 4551128 (1985-11-01), Hakim et al.
patent: 4557721 (1985-12-01), Hooven
patent: 4560375 (1985-12-01), Schulte et al.
patent: 4576035 (1986-03-01), Hooven et al.
patent: 4595390 (1986-06-01), Hakim et al.
patent: 4598579 (1986-07-01), Cummings et al.
patent: 4601721 (1986-07-01), Kamerling
patent: 4605395 (1986-08-01), Rose et al.
patent: 4610658 (1986-09-01), Buchwald et al.
patent: 4627832 (1986-12-01), Hooven et al.
patent: 4631051 (1986-12-01), Harris
patent: 4673384 (1987-06-01), Marion
patent: 4675003 (1987-06-01), Hooven
patent: 4676772 (1987-06-01), Hooven
patent: 4681559 (1987-07-01), Hooven
patent: 4705499 (1987-11-01), Hooven
patent: 4714458 (1987-12-01), Hooven
patent: 4714459 (1987-12-01), Hooven
patent: 4729762 (1988-03-01), Doumenis
patent: 4741730 (1988-05-01), Dormandy, Jr.
patent: 4769002 (1988-09-01), Hooven
patent: 4776838 (1988-10-01), Sainte-Rose et al.
patent: 4781672 (1988-11-01), Hooven
patent: 4787886 (1988-11-01), Cosman
patent: 4850955 (1989-07-01), Newkirk
patent: 4861331 (1989-08-01), East et al.
patent: 4867740 (1989-09-01), East
patent: 4885002 (1989-12-01), Watanabe et al.
patent: 4904237 (1990-02-01), Janese et al.
patent: 4931039 (1990-06-01), Coe et al.
patent: 4933156 (1990-06-01), Quay et al.
patent: 4950232 (1990-08-01), Ruzicka et al.
patent: 5039511 (1991-08-01), Quay et al.
patent: 5069663 (1991-12-01), Sussman
patent: 5167615 (1992-12-01), East et al.
patent: 5334315 (1994-08-01), Matkovich et al.
patent: 5336166 (1994-08-01), Sierra
patent: 5368556 (1994-11-01), Lecuyer
patent: 5372573 (1994-12-01), Habib
patent: 5385541 (1995-01-01), Kirsch et al.
patent: 5385582 (1995-01-01), Ommaya
patent: 5387188 (1995-02-01), Watson
patent: 5425368 (1995-06-01), Brandt
patent: 5437627 (1995-08-01), Lecuyer
patent: 5458606 (1995-10-01), Cohen et al.
patent: 5462667 (1995-10-01), Wollinsky et al.
patent: 5601985 (1997-02-01), Trojanowski et al.
patent: 5643194 (1997-07-01), Negre
patent: 5643195 (1997-07-01), Drevet et al.
patent: 5660200 (1997-08-01), Paes
patent: 5683357 (1997-11-01), Magram
patent: 5980480 (1999-11-01), Rubenstein et al.
patent: 6264625 (2001-07-01), Rubenstein et al.
patent: 6383159 (2002-05-01), Saul et al.
patent: 6575928 (2003-06-01), Saul et al.
patent: 6875192 (2005-04-01), Saul et al.
patent: 2005/0010159 (2005-01-01), Reich et al.
patent: 2005/0038371 (2005-02-01), Reich et al.
patent: 0 115 973 (1984-08-01), None
patent: 0 117 695 (1984-09-01), None
patent: 0 421 558 (1991-04-01), None
patent: 0 478 842 (1992-04-01), None
patent: 0 798 011 (1997-10-01), None
patent: 0 798 012 (2001-10-01), None
patent: 2 354 103 (1978-06-01), None
patent: 2 685 206 (1993-06-01), None
patent: 2 705 574 (1994-12-01), None
patent: 8801516 (1989-05-01), None
patent: 1297870 (1987-03-01), None
patent: WO 96/28200 (1996-09-01), None
patent: WO 98/02202 (1998-01-01), None
patent: WO 03/068049 (2003-08-01), None
Abbott, KH, MD, et al., The Central Nervous System,JAMAJul. 6, 1963, 104-115.
Barnett, GH, MD et al., Normal Pressure Hydrocephalus in Children and Young Adults,Neurosurgery, (1987) vol. 20. No. 6. 904-907.
Boon, AJW, et al., Does CSF Outflow Resistance Predict the Response to Shunting in Patients with Normal Pressure Hydrocephalus?Acta Neurochir(1988) (Suppl) 71:331-333.
Boon, AJW, et al., Dutch Normal-Pressure Hydrocephalus Study: Prediction of Outcome After Shunting by Resistance to Outflow of Cerebrospinal Fluid,J. Neurosurg(1997) 87:687-693.
Boon, AJW, et al. Dutch Normal-Pressure Hydrocephalus Study: The Role of Cerebrovascular Disease,J. Neurosurg90:221-226, 1999.
Chapman, PH, MD, et al. The Relationship between Ventricular Fluid Pressure and Body Position in Normal Subjects and Subjects with Shunts: A Telemetric Study,Neurosurgery. (1990) vol. 26, No. 2, 181-189.
Chen, IH, et al., Effectiveness of Shunting in Patients with Normal Pressure Hydrocephalus Predicted by Temporary, Cntrolled-Resistance, Continuous Lumbar Drainage: A Pilot Study.J. Neurology, Neurosurgery, and Psychiatry(1994) 57:1430-1432.
Clarfield, AM, MD. et al., Normal-Pressure Hydrocephalus: Saga or Swamp?JAMA, Nov. 10, 1989, vol. 262, No. 18, 2592-2593.
Condon, BR, et al., A Quantitative Index of Ventricular and Extraventricular Incracranial CSF Volumes Using MR Imaging,J. Computer Assisted Tomography10(5): 784-792, Sep./Oct. 1986.
Condon, B., et al., MR Relaxation Times of Cerebrospinal Fluid,J. Computer Assisted Tomography, 11(2):203-207, Mar./Apr. 1987.
Damasceno, BP, et al., The Predictive Value of Cerebrospinal Fluid Tap-Test in Normal Pressure Hydrocephalus,Arq Neurosiquiatr199755(2):179-185.
Friedland, RP, MD. ‘Normal’-Pressure Hydrocephalus and the Saga of the Treatable Dementias,JAMANov. 10, 1989, vol. 262, No. 18, 2577-2581.
Golomb, J. et al., Alzheimer's Disease Comorbidity in Normal Pressure Hydrocephalus: Prevalence and Shunt Response.J. Neurol, Neurosurgery, and Psychiatry2000, 68:778-781.
Adams et al., “Disturbances of cerebrospinal fluid circulation, including hydrocephalus and meningeal reactions,”Principles of Neurology, Fourth Edition, Chapter 30, 1989, pp. 501-502.
Adams, R.D. et al., “Symptomatic occult hydrocephalus with ‘normal’ cerebrospinal-fluid pressure”The New England Journal of Medicine, vol. 273, No. 3, pp. 117-126 (Jul. 15, 1965).
Appenzeller et al., Treatment of parenchymatous degeneration of the brain by ventriculo-atrial shunting of the cerebrospinal fluid,Journal of Neurosurgery, vol. XXVI, pp. 478-482, (Jan.-Jun. 1967).
Arai et al., “Tau in cerebrospinal fluid: a potential diagnostic marker,”Ann. Neurology, vol. 38, 1995, pp. 649-652.
Bannister et al., “Isotope encephalography in the diagnosis of dementia due to communicating hydrocephalus”The Lancet, pp. 1014-1017, (Nov. 11, 1967).
Bush et al., “Beta A-4 amyloid protein and its precursor in Alzheimer's disease,”Pharmac. Tera., vol. 56, 1992, pp. 97-117.
Frankel et al., “High affinity binding of monoclonal antibodies to the sequential epitope EFRH ofy-amyloid peptide is essential for modulation of fibrillar aggregation” J. Immunol. (1999) 95:136-142.
Frankel et al., “Modulation of Alzheimer'sy-amyloid neurotoxicity by site-directed single-chain antibody” J. Immunol. (2000) 106:23-31.
Graff-Radford et al., “Normal-pressure hydrocephalus”Neurol. (1986) 43:940-942.
Gustafson et al., “Recovery in hydrocephalic dementia after shunt operation”J. Neurol. Neurosurg. Psych.(1978) 41:940-947.
Hakim et al., “The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics”J. Neurol. Sci.(1965) 2:307-327.
Ko et al., “Cerebrospinal fluid control system” Proceedings of the IEEE, vol. 76, No. 9, pp. 1226-1235, Sep. 1988.
Martinez et al., “Relationship of interleukin-1 beta and beta2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type,”J. Neuroimmunology, vol. 48, 1993, pp. 235-240.
Mataró et al., “Cognitive changes after cerebrospinal fluid shunting in young adults with spina bifida and assumed arrested hydrocephalus”J. Neurol. Neurosurg. Psych. (2000) 68:615-621.
Nakamura et al., “Amyloid

Affiliated with

Also associated with

Rating

Methods for the treatment of a normal pressure hydrocephalus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for the treatment of a normal pressure hydrocephalus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of a normal pressure hydrocephalus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3749722